Medical and Pharmaceutical Allarity Therapeutics doses first patients in VA-funded small cell lung cancer trial The drug being examined, stenoparib, is also showing promise in ovarian cancer treatment Rowan DunneFebruary 24, 2026
Medical and Pharmaceutical Tempus AI builds on FDA win with Median partnership for lung cancer detection Median secured FDA 510(k) approval for eyonis LCS on Feb. 9 Rowan DunneFebruary 23, 2026
Medical and Pharmaceutical GRAIL plunges hard after ‘Galleri’ multi-cancer test fails to meet primary endpoint The slide comes in tandem with financial results that beat expectations Rowan DunneFebruary 20, 2026
Medical and Pharmaceutical Breath Diagnostics advances pre-op pneumonia screening with FDA breakthrough designation The FDA grants Breakthrough Device status to a limited group of technologies Joseph MortonFebruary 19, 2026
Medical and Pharmaceutical UBC scientists discover key to mass-producing helper T-cells for cancer treatment Cell therapies have gained ground in recent years as doctors turn patients’ immune systems into “living drugs.” Joseph MortonFebruary 18, 2026
Medical and Pharmaceutical Chinese researchers reveal optical sensor for early lung cancer detection The group combined DNA nanostructures, quantum dots and CRISPR gene-editing tools with a light-based technique called second harmonic generation Joseph MortonFebruary 17, 2026
Medical and Pharmaceutical BillionToOne adds pharmacogenomics, clonal filtering to Northstar cancer test Northstar Select already identifies genetic mutations in advanced solid tumors through a blood sample Joseph MortonFebruary 12, 2026
Medical and Pharmaceutical Krystal Biotech co-founder makes Forbes 250 innovators list News comes after the company attained RMAT designation from the FDA for its lung cancer drug Rowan DunneFebruary 11, 2026
Medical and Pharmaceutical Biotech operator Personalis sees 10% spike from Medicare covering lung cancer blood test The ctDNA blood draw is known for its ultrasensitive detection capabilities Rowan DunneFebruary 10, 2026
Medical and Pharmaceutical Oregon State nanomaterial eradicates breast cancer tumours in mice In mouse experiments using human breast cancer tumors, the results were striking Joseph MortonFebruary 10, 2026